期刊文献+
共找到5篇文章
< 1 >
每页显示 20 50 100
血清神经生长因子及细胞免疫水平在乳腺癌中的表达及其与临床病理特征的相关性 被引量:9
1
作者 王文慧 温媛媛 陈豪 《中国医药导报》 CAS 2020年第11期88-92,共5页
目的探讨血清神经生长因子(NGF)及细胞免疫水平在乳腺癌患者中的表达及其与临床病理特征的相关性。方法选择2015年3月~2018年2月在杭州市妇产科医院及浙江省舟山医院确诊的乳腺癌患者49例,设为观察组;选择同期入院的乳腺良性疾病患者45... 目的探讨血清神经生长因子(NGF)及细胞免疫水平在乳腺癌患者中的表达及其与临床病理特征的相关性。方法选择2015年3月~2018年2月在杭州市妇产科医院及浙江省舟山医院确诊的乳腺癌患者49例,设为观察组;选择同期入院的乳腺良性疾病患者45例,设为对照组;选择同期入院健康体检女性47名,设为正常组。采用酶联免疫吸附试验测定各组NGF表达水平;采用流式细胞仪测定各组CD3^+、CD4^+、CD8^+及CD4^+/CD8^+水平;记录并统计患者临床病理资料,分析各组和观察组乳腺癌不同临床病理资料的NGF、细胞免疫水平;采用Pearson分析NGF、细胞免疫水平与乳腺癌患者临床病理资料的相关性。结果三组NGF、细胞免疫水平比较,差异均有统计学意义(P<0.05)。观察组NGF水平高于对照组与正常组,且对照组NGF水平高于正常组,差异均有统计学意义(P<0.05)。观察组CD3^+、CD4^+及CD4^+/CD8^+水平低于对照组与正常组,CD8^+水平高于对照组与正常组,差异均有统计学意义(P<0.05);对照组与正常组CD3^+、CD4^+、CD8^+及CD4^+/CD8^+水平比较,差异无统计学意义(P>0.05)。乳腺癌组织中NGF、CD3^+、CD4^+、CD8^+及CD4^+/CD8^+水平在年龄、病理组织学类型方面比较,差异无统计学意义(P>0.05);乳腺癌组织中NGF、CD3^+、CD4^+、CD8^+及CD4^+/CD8^+水平在肿瘤最大径、病理分级、分化程度及淋巴结转移方面比较,差异均有统计学意义(P<0.05);Pearson相关性分析显示:NGF、CD8^+水平与肿瘤最大径、病理分级、分化程度及淋巴结转移呈正相关(P<0.05);CD3^+、CD4^+及CD4^+/CD8^+水平与肿瘤最大径病理分级、分化程度及淋巴结转移呈负相关(P<0.05)。结论NGF在乳腺癌患者中呈高表达,导致机体细胞免疫水平下降,且二者表达水平与病理特征具有相关性,加强NGF及细胞免疫水平测定能评估患者疾病严重程度,指导临床治疗。 展开更多
关键词 血清神经生长因子 细胞免疫水平 乳腺癌 病理特征 相关性 酶联免疫吸附试验 流式细胞
在线阅读 下载PDF
地西他滨联合CAG方案治疗老年急性髓系白血病的疗效 被引量:4
2
作者 云莎 张国栋 《中国实用医药》 2020年第30期151-153,共3页
目的研究分析地西他滨联合阿糖胞苷+阿克拉霉素+粒细胞集落刺激因子(CAG)方案治疗老年急性髓系白血(AML)病的疗效。方法50例老年髓系白血病患者,按照入院时间不同分为对照组及实验组,各25例。对照组采用CAG方案进行治疗,实验组采用CAG... 目的研究分析地西他滨联合阿糖胞苷+阿克拉霉素+粒细胞集落刺激因子(CAG)方案治疗老年急性髓系白血(AML)病的疗效。方法50例老年髓系白血病患者,按照入院时间不同分为对照组及实验组,各25例。对照组采用CAG方案进行治疗,实验组采用CAG方案联合地西他滨治疗。比较两组患者的细胞免疫指标(CD3+、CD4+)水平,用药不良反应(感染、肾功能不全、肝功能异常、恶性呕吐)发生情况。结果实验组患者的CD3+水平为(40.1±3.1)%,CD4+水平为(27.5±3.2)%;对照组患者的CD3+水平为(47.4±4.7)%,CD4+水平为(33.4±4.9)%,实验组患者的CD3+、CD4+水平均低于对照组,差异均具有统计学意义(P<0.05)。实验组患者发生感染2例、肾功能不全1例、肝功能异常1例、恶性呕吐2例,不良反应发生率为24.0%;对照组患者发生感染3例、肾功能不全1例、肝功能异常1例、恶性呕吐2例,不良反应发生率为28.0%。两组患者的不良反应发生率比较,差异无统计学意义(χ^2=0.104,P=0.747>0.05)。结论采用地西他滨联合CAG方案治疗老年急性髓系白血病能够明显改善患者的症状,抑制细胞免疫功能,同时安全性较高,值得推广使用。 展开更多
关键词 地西他滨 阿糖胞苷+阿克拉霉素+粒细胞集落刺激因子方案 老年急性髓系白血病 细胞免疫水平 用药安全性
在线阅读 下载PDF
药品
3
《中国医院院长》 2015年第7期23-23,共1页
国产埃博拉疫菡I期临床试验安全有效 3月26日,中国人民解放军总后勤部透露,世界顶级医学杂志《柳叶刀》近日发表我国2014基因型埃博拉疫苗I期临床试验研究成果。试验表明,疫苗安全性好.主要不良反应为注射部位疼痛,未发生严重不... 国产埃博拉疫菡I期临床试验安全有效 3月26日,中国人民解放军总后勤部透露,世界顶级医学杂志《柳叶刀》近日发表我国2014基因型埃博拉疫苗I期临床试验研究成果。试验表明,疫苗安全性好.主要不良反应为注射部位疼痛,未发生严重不良事件,接种后14天细胞免疫水平达到最高,28天抗体水平达到峰值,提前两周接种可以实现免疫保护。 展开更多
关键词 解放军总后勤部 埃博拉疫苗 疫苗安全性 药品 临床试验 注射部位疼痛 细胞免疫水平 《柳叶刀》
在线阅读 下载PDF
Prunella vulgaris L. extract improves cellular immunity in MDR-TB challenged rats 被引量:3
4
作者 Lu Jun Qin Rui +1 位作者 Ye Song Yang Mei 《Journal of Medical Colleges of PLA(China)》 CAS 2011年第4期230-237,共8页
Objective: To study the effect of the extract of Prunella vulgaris L. on multiple drugs resistant bacillus tuberculosis (MDR-TB). Methods: Experimental animal model in rats was induced by MDR-TB. Normal group mode... Objective: To study the effect of the extract of Prunella vulgaris L. on multiple drugs resistant bacillus tuberculosis (MDR-TB). Methods: Experimental animal model in rats was induced by MDR-TB. Normal group model group and Prunella vulgaris L. group were set up. The contents of IFN-7, IL-4, IL-10 and IL-12 were examined by ELISA. Their genome mRNAs were extracted, the target genes were amplified by PCR. RT-PCR was used to detect the mRNA levels of them. Results: The content of IFN-q, of the extract of Prunella vulgaris L. group was 1.98±0.67 pg/ml, IL-4 was 6.47±1.46 pg/ml, IL-10 was 12.13±3.43 pg/ml and IL-12 was 3.02±0.86 pg/ml. Compared with the model group, Prunella vulgaris L. group was notable difference in serum IFN-γ, IL-12 and IL-10 (P〈0.05). The mRNA levels of IFN-γ, IL-12 increased and IL-10 decreased obviously, the differences were quite significant (P〈0.05), but IL-4 had no obvious change. Conclusion: The extract of Prunella vulgaris L. can enhance the cellar immunological function in rats from up-regulation of the level of genetic transcription, accordingly provide the theory basis of healing of tuberculosis with it. 展开更多
关键词 Prunella vulgaris L. EXTRACT Multiple drugs resistant bacillus tuberculosi CYTOKINE Immunological function RATS
在线阅读 下载PDF
Inhibition of SIRT1 Increases EZH2 Protein Level and Enhances the Repression of EZH2 on Target Gene Expression
5
作者 Chih-chuan Liang 《Chinese Medical Sciences Journal》 CAS CSCD 2011年第2期77-84,共8页
Objective To study the regulatory roles of SIRT1 on EZH2 expression and the further ef-fects on EZH2's repression of target gene expression. Methods The stable SIRT1 RNAi and Control RNAi HeLa cells were establish... Objective To study the regulatory roles of SIRT1 on EZH2 expression and the further ef-fects on EZH2's repression of target gene expression. Methods The stable SIRT1 RNAi and Control RNAi HeLa cells were established by in-fection with retroviruses expressing shSIRT1 and shLuc respectively followed by puromycin selection. EZH2 protein level was detected by Western blot in either whole cell lysate or the fractional cell extract. Reverse transcription-polymerase chain reaction was performed to detect the mRNA level of EZH2. Cycloheximide was used to treat SIRT1 RNAi and Control RNAi cells for protein stability assay. Chromatin immunoprecipitation (ChIP) assay was applied to measure enrichment of SIRT1, EZH2, and trimethylated H3K27 (H3K27me3) at SATB1 promoter in SIRT1 RNAi and Control RNAi cells. Results Western blot results showed that EZH2 protein level increased upon SIRT1 de-pletion. Fractional extraction results showed unchanged cytoplasmic fraction and increased chromatin fraction of EZH2 protein in SIRT1 RNAi cells. The mRNA level of EZH2 was not affected by knockdown of SIRT1. SIRT1 recruitment was not detected at the promoter region of EZH2 gene locus. The protein stability assay showed that the protein stability of EZH2 increases upon SIRT1 knockdown. Upon SIRT1 depletion, EZH2 and H3K27me3 recruitment at SATB1 promoter increases and the mRNA level of SATB1 decreases. Conclusions Depletion of SIRT1 increases the protein stability of EZH2. The regulation of EZH2 protein level by SIRT1 affects the repressive effects of EZH2 on the target gene expres-sion. 展开更多
关键词 SIRT1 EZH2 Polycomb repression complex trimethylated H3K27
在线阅读 下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部